Comorbidities associated with vitiligo: a ten-year retrospective study
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Background: Vitiligo is a common disorder of depigmentation that has been associated with other autoimmune diseases. No recent large-scale data exist on the rates of comorbidities associated with vitiligo from the United States population. Objectives: To identify the prevalence of comorbidities as well as associated laboratory abnormalities in vitiligo patients. Methods: All medical records dating from January 1, 2000 to June 21, 2011 within the Research Patient Data Repository were evaluated retrospectively using a novel artificial intelligence-based computer program. A total of 3,280 patients carrying the diagnosis of vitiligo were identified using ICD-9 code 709.01. We randomly selected 300 patients and validated the diagnosis by manually reviewing their medical records. These results were used to create a model that was then applied to the larger set yielding 2,441 true vitiligo patients. 1,657 (68%) were diagnosed by dermatologists and 784 (32%) by non-dermatologists. We identified the prevalence of other comorbid autoimmune conditions by searching problem lists of vitiligo patients and collected laboratory data from the first available data point in the system for each patient. Results: Women were more frequently represented (57.6%) than men (42.4%). The majority of vitiligo patients were White/Caucasian (56.9%), followed by Hispanic/Latino (19.4%). 565 (23%) had one of the following comorbidities: 287 thyroid-related, 186 psoriasis, 72 rheumatoid arthritis, 59 alopecia areata, 55 inflammatory bowel disease, 53 systemic lupus and 20 type I diabetes mellitus. 41% had elevated anti-nuclear antibody levels. Almost half of the patients tested had elevated thyroid peroxidase antibodies. Over 50% of the patients tested had low or insufficient levels of 25-OH vitamin D. Conclusion: We found a high prevalence of comorbidities among individuals with vitiligo presenting to teaching hospitals in Boston, Mass. Comorbid autoimmune conditions were seen in 23% of vitiligo patients, thyroid disorders and psoriasis being the most common. Screening for these conditions, especially thyroid disorders, should be considered in vitiligo patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Comorbidities in patients with vitiligo in our study were most often higher than those reported in individuals without vitiligo from other studies (Figure 4).4,8,10,[17][18][19][20]”
From Burden of disease and treatment patterns in patients with vitiligo: findings from a national longitudinal retrospective study in the UK (2024) · cites this paper as [8]
In the citing paper
“The presence of systemic and autoimmune comorbidities, as previously reported, 8 reinforces the autoimmune nature of vitiligo.”
From Burden of disease and treatment patterns in patients with vitiligo: findings from a national longitudinal retrospective study in the UK (2024) · cites this paper as [8]
Citations
Cites
Polyglandular Autoimmune Syndromes: Immunogenetics and Long-Term Follow-Up
Dittmar, M., & Kahaly, G. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021845 · Cited by 367
A pilot study assessing the role of 25 hydroxy vitamin D levels in patients with vitiligo vulgaris
Silverberg, J. I., Silverberg, A. I., Malka, E. S., & Silverberg, N. B. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.11.024 · Cited by 119
Birlea, S. A., Costin, G., & Norris, D. A. (2008) · Current Drug Targets · doi:10.2174/138945008783954970 · Cited by 116
Statins and Prostate Cancer Diagnosis and Grade in a Veterans Population
Farwell, W. R., DʼAvolio, L., Scranton, R. E., Lawler, E. V., & Gaziano, J. M. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr108 · Cited by 114
Akay, B. N., Bozkir, M., Anadolu, Y., & Güllü, S. (2010) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2010.03605.x · Cited by 109
Generalized Vitiligo Associated Autoimmune Diseases in Japanese Patients Their Families
Narita, T., Oiso, N., Fukai, K., Kabashima, K., Kawada, A., & Suzuki, T. (2011) · Allergology International · doi:10.2332/allergolint.11-oa-0303 · Cited by 107
Perfil epidemiológico dos pacientes com vitiligo e sua associação com doenças da tireoide
Nunes, D. H., & Esser, L. M. H. (2011) · Anais Brasileiros de Dermatologia · doi:10.1590/s0365-05962011000200006 · Cited by 96
D'Avolio, L. W., Nguyen, T. M., Farwell, W. R., Chen, Y., Fitzmeyer, F., Harris, O. M., & Fiore, L. D. (2010) · Journal of the American Medical Informatics Association · doi:10.1136/jamia.2009.001412 · Cited by 73
Calcipotriene and Corticosteroid Combination Therapy for Vitiligo
Travis, L., & Silverberg, N. B. (2004) · Pediatric Dermatology · doi:10.1111/j.0736-8046.2004.21418.x · Cited by 70
Psoriasis Regression Analysis of MHC Loci Identifies Shared Genetic Variants with Vitiligo
Zhu, K., Lv, Y.-M., Yin, X., Wang, Z.-X., Sun, L.-D., He, S.-M., Cheng, H., Hu, D.-Y., Zhang, Z., Li, Y., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023089 · Cited by 62
Cited by
Lee, H. H., Gwillim, E., Patel, K. R., Hua, T., Rastogi, S., Ibler, E., & Silverberg, J. I. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.08.032 · Cited by 345
The Prevalence of Vitiligo: A Meta-Analysis
Zhang, Y., Cai, Y., Shi, M., Jiang, S., Cui, S., Wu, Y., Gao, X.-H., & Chen, H.-D. (2016) · PLOS ONE · doi:10.1371/journal.pone.0163806 · Cited by 292
Stafford, I. S., Kellermann, M., Mossotto, E., Beattie, R. M., MacArthur, B. D., & Ennis, S. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-0229-3 · Cited by 272
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial
Rosmarin, D., Pandya, A. G., Lebwohl, M., Grimes, P., Hamzavi, I., Gottlieb, A. B., Butler, K., Kuo, F., Sun, K., Ji, T., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30609-7 · Cited by 271
Current knowledge on psoriasis and autoimmune diseases
McCormick, T., Ayala-Fontanez, N., & Soler, D. (2016) · Psoriasis: Targets and Therapy · doi:10.2147/ptt.s64950 · Cited by 266
Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study
Gill, L., Zarbo, A., Isedeh, P., Jacobsen, G., Lim, H. W., & Hamzavi, I. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.08.063 · Cited by 199
Wang, X. X., Wang, Q. Q., Wu, J. Q., Jiang, M., Chen, L., Zhang, C. F., & Xiang, L. H. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14416 · Cited by 191
Comorbidities in vitiligo: comprehensive review
Dahir, A. M., & Thomsen, S. F. (2018) · International Journal of Dermatology · doi:10.1111/ijd.14055 · Cited by 148
Type I interferon signature in the initiation of the immune response in vitiligo
Bertolotti, A., Boniface, K., Vergier, B., Mossalayi, D., Taieb, A., Ezzedine, K., & Seneschal, J. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12219 · Cited by 160
Vitiligo is not a cosmetic disease
Ezzedine, K., Sheth, V. M., Rodrigues, M. A., Eleftheriadou, V., Harris, J. E., Hamzavi, I. H., & Pandya, A. G. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.07.039 · Cited by 150
Self-citationQuality of Life, Burden of Disease, Co-morbidities, and Systemic Effects in Vitiligo Patients
Elbuluk, N., & Ezzedine, K. (2017) · Dermatologic Clinics · doi:10.1016/j.det.2016.11.002 · Cited by 149
Vitiligo prevalence and quality of life among adults in Europe, Japan, and the USA
Bibeau, K., Pandya, A. G., Ezzedine, K., Jones, H., Gao, J., Lindley, A., & Harris, J. E. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.18257 · Cited by 137
Prevalence of Vitiligo and Associated Comorbidities in Korea
Lee, H., Lee, M., Lee, D., Kang, H. Y., Kim, K., Choi, G. S., Shin, J., Lee, H. J., Kim, D. H., Kim, T. H., et al. (2015) · Yonsei Medical Journal · doi:10.3349/ymj.2015.56.3.719 · Cited by 111
Sticherling, M. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.09.004 · Cited by 101
Mery‐Bossard, L., Bagny, K., Chaby, G., Khemis, A., Maccari, F., Marotte, H., Perrot, J. ‐., Reguiaï, Z., Sigal, M. ‐., Avenel‐Audran, M., et al. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13759 · Cited by 89
Vitiligo and Autoimmune Thyroid Disorders
Baldini, E., Odorisio, T., Sorrenti, S., Catania, A., Tartaglia, F., Carbotta, G., Pironi, D., Rendina, R., D’Armiento, E., Persechino, S., et al. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00290 · Cited by 88
Oxidative Stress and Immune System in Vitiligo and Thyroid Diseases
Colucci, R., Dragoni, F., & Moretti, S. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/631927 · Cited by 85
Beyond skin white spots: Vitiligo and associated comorbidities
Hu, Z., & Wang, T. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1072837 · Cited by 86
Silverberg, N. B. (2015) · Current Dermatology Reports · doi:10.1007/s13671-014-0098-6 · Cited by 80
Involvement of non‐melanocytic skin cells in vitiligo
Bastonini, E., Bellei, B., Filoni, A., Kovacs, D., Iacovelli, P., & Picardo, M. (2019) · Experimental Dermatology · doi:10.1111/exd.13868 · Cited by 74
Bezzio, C., Corte, C. D., Vernero, M., Luna, I. D., Manes, G., & Saibeni, S. (2022) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848221115312 · Cited by 66
Follicular vitiligo: A report of 8 cases
Gan, E. Y., Cario, M., Pain, C., Goussot, J., Taïeb, A., Sénéschal, J., & Ezzedine, K. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.12.049 · Cited by 65
Prevalence of Co-existing Autoimmune Disease in Rheumatoid Arthritis: A Cross-Sectional Study
Simon, T. A., Kawabata, H., Ray, N., Baheti, A., Suissa, S., & Esdaile, J. M. (2017) · Advances in Therapy · doi:10.1007/s12325-017-0627-3 · Cited by 61
The Prevalence of Thyroid Disorders in Patients With Vitiligo: A Systematic Review and Meta-Analysis
Yuan, J., Sun, C., Jiang, S., Lu, Y., Zhang, Y., Gao, X., Wu, Y., & Chen, H. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00803 · Cited by 61
Disease-Specific Health Disparities: A Targeted Review Focusing on Race and Ethnicity
Cullen, M. R., Lemeshow, A. R., Russo, L., Barnes, D. M., Ababio, Y., & Habtezion, A. (2022) · Healthcare · doi:10.3390/healthcare10040603 · Cited by 59
Co-aggregation and heritability of organ-specific autoimmunity: a population-based twin study
Skov, J., Eriksson, D., Kuja‐Halkola, R., Höijer, J., Guðbjörnsdóttir, S., Svensson, A., Magnusson, P. K. E., Ludvigsson, J. F., Kämpe, O., & Bensing, S. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0049 · Cited by 55
Dey-Rao, R., & Sinha, A. A. (2017) · BMC Genomics · doi:10.1186/s12864-017-3510-3 · Cited by 54
Hadi, A., Wang, J. F., Uppal, P., Penn, L. A., & Elbuluk, N. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.07.036 · Cited by 53
Ingordo, V., Cazzaniga, S., Raone, B., Digiuseppe, M. D., Musumeci, M. L., Fai, D., PELLEGRINO, M. A., Pezzarossa, E., Lernia, V. G. D., Battarra, V. C., et al. (2014) · Dermatology · doi:10.1159/000357807 · Cited by 50
Hamzavi, I. H., Bibeau, K. B., Grimes, P. E., Harris, J. E., van Geel, N., Parsad, D., Tulpule, M. S., Gardner, J., Valle, Y., Matewa, G. T., et al. (2023) · British Journal of Dermatology · doi:10.1093/bjd/ljad245 · Cited by 48
Malerba, M., Damiani, G. B., Radaeli, A., Ragnoli, B., Olivini, A., & Calzavara‐Pinton, P. (2015) · British Journal of Dermatology · doi:10.1111/bjd.13988 · Cited by 46
Ezzedine, K., Sénéschal, J., Silva, A. D., Préaubert, N., Lamblin, A., Delattre, C., Emery, C., Nevoret, C., Finzi, J., Bouée, S., et al. (2023) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19447 · Cited by 41
Kang, P., Zhang, W., Ji, Z., Shao, Z., & Li, C. (2022) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14717 · Cited by 40
Thyroid diseases and skin autoimmunity
Baldini, E., Odorisio, T., Tuccilli, C., Persechino, S., Sorrenti, S., Catania, A., Pironi, D., Carbotta, G., Giacomelli, L., Arcieri, S., et al. (2018) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-018-9450-7 · Cited by 39
Lack of Association of Spontaneous Coronary Artery Dissection With Autoimmune Disease
Kronzer, V. L., Tarabochia, A. D., Romero, A. S. L., Tan, N. Y. L., O'Byrne, T. J., Crowson, C. S., Turley, T. N., Myasoedova, E., Davis, J. M., Raphael, C. E., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.09.533 · Cited by 38
Vitiligo Skin Biomarkers Associated With Favorable Therapeutic Response
Yang, Q., Zhang, G., Su, M., Leung, G., Lui, H., Zhou, P., Wu, Y., Zhou, J., Xu, J., Zhang, X., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.613031 · Cited by 38
Prevalence of vitiligo in Brazil—A population survey
de Castro, C. C. S., & Miot, H. A. (2017) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12681 · Cited by 37
Ezzedine, K., Soliman, A. M., Li, C., Camp, H. S., & Pandya, A. G. (2023) · Dermatology and Therapy · doi:10.1007/s13555-023-01001-2 · Cited by 35
Epidemiology and Treatment Patterns of Patients with Vitiligo: A Real-World Analysis
Ramot, Y., Rosenberg, V., Zhou, L., & Harbers, S. (2024) · Advances in Therapy · doi:10.1007/s12325-024-02875-0 · Cited by 35
Weng, Y., Ho, H. J., Chang, Y.-L., Chang, Y.-T., Wu, C., & Chen, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-99786-9 · Cited by 30
Dermatological comorbidity in psoriasis: results from a large-scale cohort of employees
Zander, N., Schäfer, I., Radtke, M. A., Jacobi, A., Heigel, H., & Augustin, M. (2017) · Archives of Dermatological Research · doi:10.1007/s00403-017-1741-4 · Cited by 28
Association of herpes zoster and chronic inflammatory skin disease in US inpatients
Chovatiya, R., & Silverberg, J. I. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.12.073 · Cited by 25
Rios-Duarte, J., Sánchez-Zapata, M. J., & Silverberg, J. (2023) · Archives of Dermatological Research · doi:10.1007/s00403-023-02661-y · Cited by 18
Diabetes and Vulvovaginal Conditions
O’Laughlin, D. J., & McCoy, R. G. (2023) · Clinical Diabetes · doi:10.2337/cd23-0011 · Cited by 22
Chronic diseases among vitiligo patients: A case control study
Houssien, A. O. A., Houssien, R. O. A., Alajroush, W., & Kahtani, H. S. A. (2017) · Saudi Medical Journal · doi:10.15537/smj.2017.4.17551 · Cited by 22
Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review
Burlando, M., Muracchioli, A., Cozzani, E., & Parodi, A. (2021) · Case Reports in Dermatology · doi:10.1159/000514198 · Cited by 22
Eleftheriadou, V., Delattre, C., Chetty-Mhlanga, S., Lee, C., Girardat-Rotar, L., Khan, I., Mathew, A., & Thompson, A. R. (2024) · British Journal of Dermatology · doi:10.1093/bjd/ljae133 · Cited by 21
Pirfenidone‐induced photoleukomelanoderma in a patient with idiopathic pulmonary fibrosis
鶴田葵, Washio, K., Fukunaga, A., & Nishigori, C. (2015) · The Journal of Dermatology · doi:10.1111/1346-8138.13009 · Cited by 20
Blundell, A. R., Sachar, M., Gabel, C. K., & Bercovitch, L. G. (2021) · Pediatric Dermatology · doi:10.1111/pde.14714 · Cited by 19
Carubbi, F., Chimenti, M. S., Blasetti, G., Cipriani, P., Musto, A., Fargnoli, M. C., Perricone, R., Giacomelli, R., & Peris, K. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13170 · Cited by 18
Turk, M. J., & Huang, Y. H. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-025-01249-z · Cited by 15
Duan, K., Wang, J., Chen, S., Chen, T., Wang, J., Wang, S., & Chen, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1422626 · Cited by 15
Risk factors for cardiovascular diseases in patients with vitiligo: an analysis of current evidence
Liang, X., Guo, F., Zhang, M., Wang, C., Lin, N., Liu, L., Chen, Y., Liu, F., Du, Y., Li, L., et al. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2326297 · Cited by 15
Prevalence of cutaneous comorbidities in psoriatic patients and their impact on quality of life
Caldarola, G., SIMONE, C. D., Talamonti, M., Moretta, G., Fossati, B., Bianchi, L., Fargnoli, M. C., & Peris, K. (2019) · European Journal of Dermatology · doi:10.1684/ejd.2019.3529 · Cited by 15
Association of Other Autoimmune Diseases With Thyroid Eye Disease
Kelada, M., Avari, P., Farag, S., Akishar, R., Jain, R., Aziz, A., Feeney, C., Bravis, V., Meeran, K. M., & Lee, V. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.644200 · Cited by 14
An Extensive Review of Vitiligo-Associated Conditions
Premkumar, M., Kalarani, I. B., Mohammed, V., & Veerabathiran, R. (2023) · International Journal of Dermatology and Venereology · doi:10.1097/jd9.0000000000000346 · Cited by 14
Sendrasoa, F. A., Ranaivo, I. M., Sata, M., Andrianarison, M., Raharolahy, O., Rakotoarisaona, M. F., Razanakoto, N. H., Ramarozatovo, L. S., & Rabenja, F. R. (2019) · International Journal of Dermatology · doi:10.1111/ijd.14510 · Cited by 14
Vitiligo: Klinik und Pathogenese
Schild, M., & Meurer, M. (2016) · Der Hautarzt · doi:10.1007/s00105-015-3751-5 · Cited by 13
Patients with autoimmune skin diseases are at increased risk of adverse pregnancy outcomes
Keum, H., Bermas, B. L., Patel, S., Jacobe, H. T., & Chong, B. F. (2023) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2023.101226 · Cited by 11
Howell, M. D., Kuo, F. I., Rumberger, B., Boarder, E., Sun, K., Butler, K. A., Harris, J. E., Grimes, P. E., & Rosmarin, D. M. (2023) · JID Innovations · doi:10.1016/j.xjidi.2023.100230 · Cited by 9
Liu, J., Matangi, S., Malempati, Y., Nasir, A., & Rosmarin, D. M. (2025) · Dermatology and Therapy · doi:10.1007/s13555-025-01506-y · Cited by 9
The prevalence of autoimmune endocrine diseases in vitiligo patients
Troshina, E. A., Волнухин, В. А., Petrov, V., Nuralieva, N. F., Yukina, M. Y., Orlova, E., & Frigo, N. V. (2020) · Terapevticheskii arkhiv · doi:10.26442/00403660.2020.10.000736 · Cited by 8
Mufti, A. H., AlJahdali, I. A., Elhawary, N. A., Ekram, S. N., Abumansour, I. S., Sindi, I. A., Naffadi, H. M., Elhawary, E. N., Alyamani, N. M., Alghamdi, G., et al. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s341079 · Cited by 7
Sénéschal, J., Morice‐Picard, F., & Taïeb, A. (2019) · Springer eBooks · doi:10.1007/978-3-319-62960-5_13 · Cited by 8
Accelerating bleaching in vitiligo: balancing benefits versus risks
Sénéschal, J., Boniface, K., Ezzedine, K., & Taïeb, A. (2014) · Experimental Dermatology · doi:10.1111/exd.12508 · Cited by 7
Cohen, N. T., Schonmann, Y., & Kridin, K. (2024) · Archives of Dermatological Research · doi:10.1007/s00403-024-02965-7 · Cited by 7
A case control study of vitamin D levels in patients with vitiligo
Devan, P., & Karthikeyan, K. (2017) · International Journal of Research in Dermatology · doi:10.18203/issn.2455-4529.intjresdermatol20170796 · Cited by 7
Cao, L., Zhang, R., Wang, Y., Hu, X., Liang, Y., Li, B., Ge, H., Chen, W., Zhen, Q., Yu, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.758652 · Cited by 8
Tordjman, L., Mashoudy, K. D., & Czarnowicki, T. (2025) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2025.04.016 · Cited by 6
Biobanks and Artificial Intelligence
Abdulkareem, M., Aung, N., & Petersen, S. E. (2022) · Contemporary medical imaging · doi:10.1007/978-3-030-92087-6_8 · Cited by 6
Ray, M. D., Gandhi, K., Maughn, K., & Pandya, A. G. (2023) · JID Innovations · doi:10.1016/j.xjidi.2023.100199 · Cited by 6
Li, B., Zhu, G., Kang, P., Chen, J., He, K., Wang, X., Gao, T., Li, C., & Li, S. (2023) · Experimental Dermatology · doi:10.1111/exd.14904 · Cited by 5
Identification of Hub Genes in Comorbidity of Psoriasis and Vitiligo Using Bioinformatics Analysis
Wang, C., Yuan, J., Yu, H., Lin, J., & Bai, B. (2024) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s470149 · Cited by 5
Fekete, L., Fekete, G. L., Iantovics, L. B., Fekete, J. E., & Bacârea, V. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1544184 · Cited by 5
Wang, B., Sun, J., & Tong, J. (2021) · BMC Surgery · doi:10.1186/s12893-021-01097-3 · Cited by 5
Exploring genetic associations between vitiligo and mental disorders using Mendelian randomization
Wang, Y.-W., Yao, T., Lin, Y., Ye, L., Li, S., Gao, Y., & Wu, J. (2023) · Experimental Dermatology · doi:10.1111/exd.14979 · Cited by 5
Frequency of positive thyroid peroxidase antibody levels in patients of generalized vitiligo
Ashraf, A., Azfar, N. A., Chaudhry, A., Rasul, A., Irfan, M., & Liaqat, Z. (2022) · Journal of Pakistan Association of Dermatologists · doi:10.66344/jpad.v31i4.1758 · Cited by 5
Sajjad, S., Munir, S., Rahman, S. B., Saba, N., & Rehman, S. (2018) · Journal of Pakistan Association of Dermatologists · doi:10.66344/jpad.v27i2.1074 · Cited by 5
Boza, J. C. (2016) · Americanae (AECID Library) · Cited by 5
Costa, A. F. D., Ashkanani, H., Ferreira, C., & Torres, T. R. (2026) · Journal of International Medical Research · doi:10.1177/03000605261444465 · Cited by 4
Emerging Uses of Artificial Intelligence in Chronic Dermatologic Disease: A Scoping Review
Hollman, D., Doktorchik, C. T. A., & Mukovozov, I. (2024) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/12034754241308237 · Cited by 4
Primary Neurologic Symptoms: Have You Considered Pernicious Anemia?
Yocum, A. D., Patel, M., Palocko, B., & Simon, E. L. (2023) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2022.10.024 · Cited by 4
Huang, J., Jiang, L., Hu, Y., Fu, C., Zhang, K., Wen, Y., Shu, Z., Huang, J., Chen, J., & Zeng, Q. (2025) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.70211 · Cited by 4
Automated Mass Screening for Comorbidities of Vitiligo Using the National Health Insurance Database
Han, J. H., Lee, S., Ju, H. J., Kim, M., Choi, C. W., & Bae, J. M. (2023) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2023.02.031 · Cited by 4
Karagün, E. (2019) · International Journal of Innovative Research in Medical Science · doi:10.23958/ijirms/vol04-i10/769 · Cited by 4
Comorbid autoimmune pathology in patients treated with disease modifying drugs
Goncharova, Z. A., Sizyakinа, L. P., Belovolova, R. A., & Megeryan, V. A. (2016) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201611610253-60 · Cited by 3
Kang, P., Zhang, W., Ji, Z., Shao, Z., & Li, C. (2022) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14717_g · Cited by 3
Zhu, Q., He, Y., Chen, S., & Zhang, G. (2024) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s475002 · Cited by 3
Chin, H. W., Jamil, A., Sarkan, M. M., & Tang, J. J. (2025) · Photodermatology Photoimmunology & Photomedicine · doi:10.1111/phpp.70015 · Cited by 3
Dermatoses Most Frequently Related to Diabetes Mellitus
Sabban, E. N. C. (2017) · Springer eBooks · doi:10.1007/978-3-319-72475-1_11 · Cited by 3
Autoimmune Factors in the Ethiopathogenesis of Vitiligo
Lukinović-Škudar, V. (2015) · MOJ Anatomy & Physiology · doi:10.15406/mojap.2015.01.00012 · Cited by 3
Vitiligo and autoimmune diseases
Kutwin, M., Sysa‐Jędrzejowska, A., & Woźniacka, A. J. (2016) · Dermatology Review · doi:10.5114/dr.2016.62892 · Cited by 3
Ruxolitinib cream for the treatment of vitiligo – Authors' reply
Rosmarin, D. M., Butler, K. A., Kuo, F. I., & Harris, J. E. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32470-3 · Cited by 3
Gu, Z., & Teng, J. (2026) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2026.25282 · Cited by 2
Vitiligo: A black patch on white skin is a blessing—but a white patch on black skin is a curse
Ghia, D., & Mysore, V. N. (2022) · Dermatological Reviews · doi:10.1002/der2.150 · Cited by 3
What is that white spot on my face?
Morriss, S., Gan, C., & Rodrigues, M. A. (2023) · Australian Journal of General Practice · doi:10.31128/ajgp-01-23-6682 · Cited by 2
Vitiligo: concomitant autoimmune and allergic diseases
Kądziela, M., Woźniacka, A. J., Dziankowska–Zaborszczyk, E., & Kutwin, M. (2024) · Alergologia Polska - Polish Journal of Allergology · doi:10.5114/pja.2023.134244 · Cited by 2
RETRACTED: Identifying the genetic association between common rheumatic diseases and vitiligo
Zhao, M., Zhang, Y., & Sun, G. (2024) · Skin Research and Technology · doi:10.1111/srt.13846 · Cited by 2
RetractedEtiopathogenetic Similarities of Combined Forms of Localized Scleroderma and Vitiligo
Murashkin, N. N., Savelova, A. A., Ivanov, R. A., Ambarchian, E. Т., Materikin, A. I., Epishev, R. V., & Opryatin, L. A. (2020) · Вопросы современной педиатрии · doi:10.15690/vsp.v19i6.2147 · Cited by 2
Patogénesis de vitíligo. Teoría autoinmune
Cruz, F. J., Morales‐Sánchez, M. A., Pérez‐Montesinos, G., Pedrero, M. L. P., Ortega, X. T., & Guerrero-Oliva, G. (2020) · Revista del Centro Dermatológico Pascua · doi:10.35366/99918 · Cited by 2
Metadata
- Authors
- Sheth, V. M., Guo, Y., & Qureshi, A. A.
- Affiliations
- Brigham and Women's Hospital (US)
- Venue
- Dermatology
- Publisher
- S. Karger AG
- Published
- 2013
- Volume
- 227
- Issue
- 4
- Pages
- 311-315
- ISSN
- 1018-8665 (ISSN-L)
- 1421-9832
- OpenAlex
- W2054293537
- Cited by
- 128
- References
- 17
- Citations by year
- 2026: 8 · 2025: 5 · 2024: 13 · 2023: 19 · 2022: 10 · 2021: 12 · 2020: 11 · 2019: 9 · 2018: 4 · 2017: 12 · 2016: 10 · 2015: 10 · 2014: 5
- FWCI
- 4.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Dermatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Dermatology › Hair Growth and Disorders
- Keywords
- vitiligo, comorbidities, autoimmune disease, thyroid dysfunction, psoriasis, rheumatoid arthritis, alopecia areata, inflammatory bowel disease, systemic lupus erythematosus, type 1 diabetes, antinuclear antibodies, thyroid peroxidase antibodies, vitamin D deficiency, prevalence, screening
- MeSH terms
- Alopecia Areata, Antibodies, Antinuclear, Arthritis, Rheumatoid, Boston, Diabetes Mellitus, Type 1, Female, Humans, Iodide Peroxidase, Lupus Erythematosus, Systemic, Male, Middle Aged, Psoriasis, Retrospective Studies, Sex Factors, Thyroid Diseases, Vitamin D, Vitiligo, Inflammatory Bowel Diseases, Comorbidity, Prevalence, Racial Groups
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.